Detailed medication instructions for patients with the targeted drug dasatinib (Startase)

Drug name: Dasatinib (Dasatinib)

Drug type: Targeted drugs

1. Indications: Dasatinib (Stacer) is used to treat specific types of leukemia, including chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). In CMLpatients, especially those who carry Philadelphia chromosomes, dasatinib (Startase) has shown significant efficacy.

2. Mechanism of action: Dasatinib (Stacer) is a tyrosine kinase inhibitor that inhibits the proliferation and survival of leukemia cells by inhibiting abnormally active tyrosine kinases in leukemia cells, especially the kinase activity of the BCR-ABL fusion gene product.

3. Usage and dosage: Chronic myeloid leukemia in chronic phase: 100mg orally, once a day; Accelerated phase of chronic myeloid leukemia, bone marrow or lymphoblastic leukemia, Ph+ ALL: 140mg, orally, once a day. During treatment, the dose may need to be adjusted based on the patient's condition.

4. Precautions when using medication:

1.Avoid taking with food: Avoid taking with food containing high fat and high calories, as this may affect the absorption of the drug.

2.Take medicine on time: Patients should follow the doctor’s recommendations, take medicine on time every day, and do not miss doses or interrupt treatment.

3.Adjust the dosage according to the doctor's advice: Patients should not change the dosage of dasatinib (Celtaside) on their own and should adjust it according to the doctor's advice and instructions.

4.Monitor and report adverse reactions: During treatment, patients should closely monitor their health status and promptly report any adverse reactions, such as headache, vomiting, diarrhea, rash, etc. to their doctor.

5.Liver function monitoring: Dasatinib (Startase) may cause liver function abnormalities, so patients should undergo regular liver function tests during treatment.

6.Cardiac monitoring: Dasatinib (Startase) may cause cardiotoxicity, and patients should receive regular electrocardiograms and cardiac function assessments during treatment.

7.Avoid taking it during pregnancy: Dasatinib (Startase) may cause damage to the fetus. Pregnant women should avoid taking it during pregnancy. If you are pregnant or planning to become pregnant, you should inform your doctor before treatment.

8.Avoid alcohol and drug interactions: Patients should avoid drinking alcohol during treatment because alcohol may interact withdasatinib (Startax) and increase the risk of adverse reactions. At the same time, patients should report other medications they are taking to their doctors to avoid drug interactions.

5. Storage requirements: Dasatinib (Startase) should be stored at room temperature (15-30 degrees Celsius), away from light and moisture, and avoid storage in a humid environment.

6. Handling Overdose: If the patient accidentally takes an overdose ofdasatinib (Celtaside) , he should seek medical attention immediately and inform the doctor of the dose and time of taking.

7. Withdrawal: If the patient needs to stop dasatinib (Stacer) treatment, the dose should be gradually reduced under the guidance of a doctor instead of suddenly stopping the medication.

8. Availability and price: Dasatinib (Dasatinib) is now available in China and has been included in the medical insurance system. Patients can purchase it directly in China, with the price ranging from RMB 4,000 to RMB 5,000. For specific drug pricing and medical insurance reimbursement ratios, patients are asked to go to the pharmacy of their local hospital for detailed consultation. In addition, the price of foreign generic drugs of Dasatinib (Stardas) is relatively more affordable, usually only a few hundred yuan, which has a significant price advantage over domestic prices. It is worth noting that the ingredients of original drugs marketed in China and foreign generic drugs are highly consistent. Therefore, when patients choose drugs, they can make reasonable choices based on their actual situation and economic conditions.

Dasatinib is an effective anticancer drug, but some adverse effects may occur during use. Patients should follow their doctor's recommendations and medication instructions, closely monitor their health, and seek prompt medical treatment for any adverse reactions. At the same time, patients should receive regular follow-up and examinations from doctors to ensure the effectiveness and safety of treatment.